Cor Vasa 2012, 54(3-4):205-206

Česko-slovenský projekt MAUR

Prof. MUDr. Vladimír Tesař, DrSc., FASN, FERA
Klinika nefrologie, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice, Praha

Published: March 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tesař V. Česko-slovenský projekt MAUR. Cor Vasa. 2012;54(3-4):205-206.
Download citation

References

  1. Volpe M. Microalbuminuria screening in patients with hypertension: recommendations for clinical practice. Int J Clin Pract 2008;62:97-108. Go to original source... Go to PubMed...
  2. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-1536. Go to original source... Go to PubMed...
  3. Cerezo C, Ruilope LM, Segura J, et al. Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression. J Hypertens 2012;30:204-9. Go to original source... Go to PubMed...
  4. Donnelly R, Yeung JM, Manning G. Microalbuminuria: a common, independent cardiovascular risk factor, especially, but not exclusively in type 2 diabetes. J Hypertens, 2003;21(Suppl.):S7-S12.




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.